Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Indian-origin hematologist-oncologist, Vinay Prasad, a vocal critic of Covid-19 norms like mask policies and booster shots, ...

Regulatory Activities: In April 2025, Sanofi and Regeneron Pharma received approval from the U.S. FDA for Dupixent (dupilumab) to treat adults and adolescents aged 12 years and older with chronic ...